PER 1.18% 8.4¢ percheron therapeutics limited

They show slight increases in dystrophin, it’s just a case of...

  1. 720 Posts.
    lightbulb Created with Sketch. 210

    They show slight increases in dystrophin, it’s just a case of where you draw the line and define “efficacy”. It’s thought that at least 10% of normal dystrophin levels are required for any noticeable improved physical effect, and the improvements caused by the drug still leave the child with less than 1% of normal levels.

    I go back to a point I made over a year ago, in light of DMD parents signing a petition that influenced the FDA’s decision - what Sarepta are selling to parents of newly diagnosed DMD patients is “hope” at little expense to those who get full health coverage, and at a stage when the prognosis is horrible to contemplate, but not yet played out.

    Parents would do anything to keep hope of a cure or just an improvement alive.

    The EMA rejected the application.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢
Change
-0.001(1.18%)
Mkt cap ! $75.72M
Open High Low Value Volume
8.4¢ 8.4¢ 8.3¢ $3.097K 37.23K

Buyers (Bids)

No. Vol. Price($)
1 29206 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 118557 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.